Table 2. Characteristics of studies for association between mbl2 polymorphisms and HBV infection.
Study | Ethnicity | Control | Cases | Polymorphisms included | Genotyping Methods | HWE |
---|---|---|---|---|---|---|
Thomas HC 1996 [8] | Caucasian | HC/SR | CHB | Condon52, 54 and57 | SSOP; sequencing | No |
Asian | HC | CHB | Condon52, 54 and57 | SSOP; sequencing | Yes | |
Bellamy R 1998 [9] | African | HC/SR | CHB | Condon52, 54 and57 | SSOP | Yes |
Höhler T 1998 [10] | Caucasian | HC/SR | CHB | Condon52 and 54 | PCR-RFLP | Yes |
Yuen MF 1999 [11] | Asian | HC | CHB/LC/HCC | Condon54 | PCR-RFLP | − |
Shi H 2001 [12] | Asian | HC | CHB | Condon52, 54 and 57 | PCR-RFLP | Yes |
Hakozaki Y 2002 [13] | Asian | HC | SHB | Condon52, 54 and 57; -221Y/X | sequencing | No |
Song le H 2003[1] | Asian | HC | CHB/LC/HCC | Condon52, 54 and57 | sequencing | Yes |
Cheong JY 2005 [14] | Asian | SR | CHB | Condon54 | SBE | Yes |
Thio CL 2005[15] | A mixed population | SR | CHB | Mbl2 promoter and exon1 combined polymorphisms | Real time PCR | − |
Chong WP 2005 [16] | Asian | HC/SR | CHB/LC/HCC | Mbl2 promoter and exon1 combined polymorphisms | TaqMan PCR | Yes |
Segat L 2008 [17] | Caucasian | HC | HCC | Condon52, 54 and57 | Real time PCR | Yes |
Tong FY 2008 [18] | Asian | HC | CHB/SHB | Condon52, 54 and 57 | sequencing | − |
Filho RM 2010 [19] | A mixed population | HC | CHB | Condon52, 54 and 57; -221Y/X | Taqman PCR | Yes |
Fletcher GJ 2010 [20] | A mixed population | SR | CHB | Condon52, 54 and 57; -221Y/X | PCR-SSP | − |
Chen DQ 2010 [21] | Asian | SR | CHB | Condon54 and -221Y/X | PCR-RFLP | Yes |
Chatzidaki V 2012 [22] | Caucasian | HC/SR | CHB | Condon54 and 57; -221Y/X | PCR-RFLP | Yes |
Zheng RD 2012 [23] | Asian | HC/SR | CHB/SHB/LC | Condon54 | PCR-RFLP | Yes |
RFLP: restriction fragment length polymorphisms; SSOP: sequence specific oligonucleotide probes; PCR-SSP: polymerase chain reaction-sequence specific primer; SBE: Single Base Primer Extension Assay. HWE: Hardy-Weinberg equilibrium; − not available. HC: healthy control; SR: spontaneous recovered control; CHB: chronic hepatitis B; LC: liver cirrhosis; HCC: hepatocellular carcinoma; SHB: severe hepatitis B.